+

WO1996002629A2 - Process for releasing heterolog proteins of saccharomyces cerevisiae strains - Google Patents

Process for releasing heterolog proteins of saccharomyces cerevisiae strains Download PDF

Info

Publication number
WO1996002629A2
WO1996002629A2 PCT/ES1995/000088 ES9500088W WO9602629A2 WO 1996002629 A2 WO1996002629 A2 WO 1996002629A2 ES 9500088 W ES9500088 W ES 9500088W WO 9602629 A2 WO9602629 A2 WO 9602629A2
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
protein
saccharomyces cerevisiae
release
cells
Prior art date
Application number
PCT/ES1995/000088
Other languages
Spanish (es)
French (fr)
Other versions
WO1996002629A3 (en
WO1996002629B1 (en
Inventor
César NOMBELA CANO
Pablo Alvarez Alvarez
Marta Sampedro Martinez
Jesús DE LA FUENTE CARRETERO
María Molina Martin
Original Assignee
Universidad Complutense De Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Complutense De Madrid filed Critical Universidad Complutense De Madrid
Priority to AU30787/95A priority Critical patent/AU3078795A/en
Publication of WO1996002629A2 publication Critical patent/WO1996002629A2/en
Publication of WO1996002629A3 publication Critical patent/WO1996002629A3/en
Publication of WO1996002629B1 publication Critical patent/WO1996002629B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms
    • C12N1/063Lysis of microorganisms of yeast

Definitions

  • the present invention falls within Biotechnology and specifically in the field of expression, production and release of heterologous proteins in yeast.
  • the invention provides a method for carrying out said release, based on simple treatments of certain strains of Saccharomyces cerevisiae, carriers of a mutation that leads to the release of intracellular content, thus obtaining protein preparations that are easily separated from the greater part of the undesirable cellular materials present in said preparations, such as cell walls. Protein preparations thus obtained can be subjected to the corresponding extraction and purification processes.
  • the mutation of which Saccharomyces cerevisiae cells are used in the process object of this invention affects the gene called SLT2; as a consequence of said mutation, the cells lose their integrity under certain conditions which leads to the release of their soluble protein content.
  • the existing knowledge about the function of the aforementioned gene largely developed in our laboratory, allows us to take advantage of the characteristics of this type of mutant cells to optimize said protein release.
  • the process object of this invention represents an alternative to other methods of releasing heterologous yeast proteins such as mechanical, chemical or enzymatic breakage of cellular integrity.
  • yeast Saccharomyces cerevisiae is a well known organism and widely used in Biotechnology for the expression and production of heterologous proteins. Several characteristics of this species stand out in relation to its usefulness:
  • Yeasts are used to produce a series of heterologous proteins. of high added value, as a consequence of a process of expression of the corresponding genes, in processes in which the protein accumulates at the intracellular level.
  • these are the surface antigen of the hepatitis B virus (HBV) that has given rise to the development of a recombinant vaccine already on the market, human proinsulin, human superoxide dismutase, VLP proteins as presenters of HIV1 virus antigens and the antigen that has allowed to develop a vaccine against malaria.
  • HBV hepatitis B virus
  • human proinsulin human superoxide dismutase
  • VLP proteins as presenters of HIV1 virus antigens and the antigen that has allowed to develop a vaccine against malaria.
  • the possibilities in this regard are widely collected in Romanos, M.A., Scorer, C.A. and Clare, J.J. 1992, Foreign gene expression in yeast: a review. Yeast 8: 423-488.
  • cell breakage is usually used.
  • the traditional methods described for achieving said cell rupture are drastic due to the hardness of the Saccharomyces cerevisiae cell wall and may consist of: - mechanical rupture with pressure homogenizers (Scdazzling, H. and
  • VLPs recombinant proteins particles
  • SUBSTITUTED SHEET Protein extraction is not always easy to eliminate and, in the case of the use of lithic enzymes.
  • Protease contamination (Asenjo, JA, Ventom.AM. Huang, RB and Andrews. BA 1993. Selective relay of recombinant proteins particles (VLPs) fro yeast using a puree lytic glucanase enzyme. Bio / echnology 11: 214-217) that They are usually present in the aforementioned complexes of lytic enzymes.
  • the alternative of carrying out a purification to eliminate proteases increases the value of the lithic complex that is already expensive in itself.
  • Saccharomyces cerevisiae carrying the sltl mutation that is to say it affects the gene
  • the SLT2 gene encodes a protein with phosphorylating activity of proteins, which is part of the group called "Protein kinase type MAP" (Mitogen Activated Protein) (Mart ⁇ n, H., Arroyo, J., Sánchez, M .. Molina, .M. And Nombela. C. 1993. Activity of the yeast MAP kinase homologue Slt2 is critically required for cell integrity at 37 ° C. Mol. Gen. GeneL 241: 177-184) and whose biological action seems to be framed in a route of signal transmission activated by the protein kinase Cl, the signal that triggers the activation of the route as well as the final substrate thereof is currently unknown.
  • Protein kinase type MAP Mitogen Activated Protein
  • yeast proteases Another factor to consider when addressing the expression of heterologous proteins in yeasts is the possibility of nonspecific proteolytic degradation of the corresponding protein, produced by the action of yeast proteases, especially those of vacuolar origin such as those encoded by PEP4 and -P ⁇ -S7 genes (Wingfield, JM and Dickinson, JR 1993. Increased activity of a model heterologous protein in Saccharomyces cerevisiae strains with reduced vacuolar proteinases. Appl. Microbiol. Biotechnol. 39: 211-215; Jones, EW 1991 Tackling the protease problem in Saccharomyces cerevisiae Meth in Enzymol 194: 428-453;
  • strains more suitable for our invention that is, carriers of the lithic character (slt2), but which are also deficient in vacuolar proteases.
  • the first studies of heterologous protein release according to the procedure of this invention were performed by inducing cell lysis by thermal shock, consisting of raising the temperature of the culture from 24 ° C to 37 ° C, reaching 6 to 8 hours maximum protein release, as that is the time required to achieve a culture lysis.
  • the patent process consists in the use of different strains of Saccharomyces cerevisiae, deficient in the function of the SLT2 gene, whose phenotype is characterized by:
  • -Thermosensitive growth so that the cells develop well at 24 ° C but stop growing and lysate when the temperature rises to 37 ° C, producing cell lysis with release of intracellular content to the external medium.
  • -sltl mutant cells are protected against the deficiencies indicated above, ie thermosensitivity and lysis at 37 "C, by osmotic stabilization of the medium with 0.5M sorbitol or 1.5% NaCl, which is indicative of the protein encoded by the referred gene is necessary for the formation of an osmotically stable cell wall at the temperature of 37 ° C.
  • the objective of the invention is to take advantage of these phenotypic characteristics to achieve the release of intracellularly produced heterologous proteins. Said release is based on the cell lysis that occurs under certain conditions and that leads to the release of intracellular content that said mutant strains present when the growth temperature rises from 24 * C to 37 * C or when, after growing at 37 * C but in an osmotically stabilized medium, they are subjected to an osmotic shock by simple resuspension of the cells in a medium lacking said osmotic stabilizer. It is obtained in this way
  • SUBSTITUTED SHEET a protein preparation, which is separated from the remains of the cellular material by simple centrifugation, and in which the intracellular heterologous proteins are present in amounts greater than 50% of the total intracellular protein produced.
  • strains of Saccharomyces cerevisiae developed to carry out the invention are:
  • - LD1 is a diploid strain carrying the slt2 mutation with the phenotypic characteristics listed above. Its genotype is: MATa MATa, slt2D-35 / slt2D-35, Ieu2-3.U2 / Ieu2-3.U2, his4 ⁇ 34 / his4A34.
  • - LHDP1 MAT a, slt2D-35, ade2-101, leu2-3.112, pep4 :: HIS3, pbrlA1.6R. It shows the same phenotypic characteristics related to lysis, being also deficient in vacuolar proteases Pep4 and Prbl responsible for the nonspecific proteolysis.
  • strains are deposited in the Spanish Type Culture Collection (CECT) located at the University of Valencia.
  • CECT Spanish Type Culture Collection
  • the access numbers are: 10815 for strain LD1 and 10816 for strain LHDP1.
  • SUBSTITUTED SHEET B Protein release by thermal shock.
  • the phases of the process are:
  • the main advantage over the similar system based on the use of the srbl mutation is the greater sensitivity to osmotic shock of the slt2 mutation in which 60-70% of the cells are lysed against 20% of the cells mutated in - yrW (Broker, M. 1994. Isolation of recombinant proteins from Saccharomyces cerevisiae by use of osmoücally fragüe mutant strains. Biotechniques 16: 604-610).
  • Figure I shows the phases of the process of releasing intracellular heterologous proteins in strains of Saccharomyces cerevisiae mutated in the SLT2 gene by means of an osmotic shock.
  • the four panels in Figure II describe the release of homologous (alkaline phosphatase) and heterologous (chloramphenicol acetyl transferase) proteins from the strains of Saccharomyces cerevisiae LDl (A, C) and LHDPl (B, D) transformed with the plasmid pCHIOOL under conditions of expression of the slt2 mutation. Crops made in a 101-fermentor incubated at 24 ° C throughout the crop (A and B) or changed at 37 ° C (C and D) (T, temperature change).
  • the parameters measured were: +, viability measured as a percentage of IP cells (-),, Optical Density at 600 nm (OD); X, Total protein in the culture medium (Prot.); *, chloramphenicol acetyl transferase (CAT) activity in cell extracts (EC) and •, culture medium (M) as units per milliliter; *, alkaline phosphatase (PA) activity in cell extracts (EC) and A, culture medium (M) as units per milliliter.
  • CAT chloramphenicol acetyl transferase
  • EC chloramphenicol acetyl transferase
  • M culture medium
  • PA alkaline phosphatase
  • strains of Saccharomyces cerevisiae used are those described previously in the section "Explanation and Description of the Invention";
  • an optional wild strain can be used for the lithic character that serves as a negative control in the experiment, for example we have used:
  • - BJ5461 It is a wild strain for the SLT2 gene accessible to the public in the collection called Yeast Genetic Stock Center (Mortimer, R.K. and Contopoulou, R. Yeast Genetic Stock Center Catalog. Seventh edition 1991). However, any non-lyric strain can be used as a control strain for the experiments.
  • the three strains (LDl, LHDPl and BJ5461) are transformed with the plasmid pCHIOOL (Hadfield, C, Cashmore, AM and Meacock, PA 1986.
  • pCHIOOL Hadfield, C, Cashmore, AM and Meacock, PA 1986.
  • An efficient chloramphenicol resistance marker for Saccharomyces cerevisiae and Escherichia coli. Gene 45: 149-158) modified in our laboratory by introducing a LEU2 marker (leucine) to select transformants.
  • the plasmid encodes the CAT (Chloramphenicol Acetyl Transferase) protein of bacterial origin and responsible for chloramphenicol resistance and is a heterologous protein for yeast and is also produced intracellularly and therefore will only be detectable in the culture medium as consequence of cell lysis.
  • CAT Chloramphenicol Acetyl Transferase
  • the transformed strains are grown in liquid YEPD medium supplemented with an osmotic stabilizer (0.5M sorbitol, 1.5% NaCl) at a temperature of 37 ° C on a thermostated stirrer until half of the exponential phase.
  • an osmotic stabilizer 0.5M sorbitol, 1.5% NaCl
  • SHEET Cells to separate them from the culture medium are taken samples of supernatant and cells to obtain reference values about the release of CAT to the external medium (they are negative because the absence of lysis causes that there is no release of intracellular content to the external medium ).
  • the values to be measured are the activity of CAT in the cell extract and in the supernatant before and after the osmotic shock to establish the amount of protein released from the cells to the supernatant, following a colorimetric method described by Hadfield, C, Cashmore , AM and Meacock, PA 1986.
  • the cells are separated by centrifugation at 5000rpm for 5 ', then they are resuspended in water, at which time another sample is taken again by centrifuging the cell debris at 5000rpm for 10 min and analyzing the amount of CAT present in the cells and in the supernatant showing the data in table I, this preparation obtained after the second centrifugation leaves a protein preparation ready to undertake a process of purification of the protein of interest.
  • the wild strain in this case BJ5461, is not osmotically sensitive and there is no occurrence of CAT activity in the supernatant, unlike the other two strains that are sensitive to osmotic shock and have a 60-70 % of its activity in the supernatant.
  • Highlights the higher productivity of the LHDPl strain in accordance with what has been published in other studies (Romanos, MA, Scorer, CA and Clare, JJ 1992, Foreign gene expression in yeast: a review. Yeast 8: 423-488; Wingfield, JM and Dickinson, JR 1993. Increased activity of a model heterologous protein in Saccharomyces cerevisiae strains with reduced vacuolar proteins. Appl. Microbiol.
  • Table I Release of the heterologous CAT protein by osmotic shock of strains slt2. Samples of equal cell density were taken and the CAT activity was detected in: cell extract (before and after the osmotic shock), culture medium or water supernatant in which the cells were resuspended after the osmotic shock.
  • SUBSTITUTED SHEET B Protein release by thermal shock. The data obtained in type experiments are shown in Figure II.
  • the inoculum was obtained by culturing the cells at 24 ° C in minimal medium without leucine to ensure 100% plasmid carrying cells. Its volume was 500ml and corresponded to a stationary phase culture.
  • the crop was batch type. -the stirring speed was 300rpm, the pH ranged between 4 and 6, the air inlet flow 5 1 / min.
  • the two strains present protein release to the external environment represented by the increase observed in total proteins, measured by the Bradford method (Bradford, MM 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principie of protein -dye binding. Analyt. Biochem. 72: 248-254), and in the enzymatic activity CAT (Hadfield, C, Cashmore, AM and Meacock, PA 1986. An efficient chloramphenicol-resistance marker for Saccharomyces cerevisiae and Escherichia coli. Gene 45 : 149-158).
  • the stability of the CAT enzyme proves to be superior in the LHDP1 strain than in the LDl, probably due to not being exposed to the action of the vacuolar proteases Pep4 and Prbl in the case of the LHDP1 strain.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to a process for releasing intracellular heterolog proteins in the Saccharomyces Cerevisiae yeast based on the osmotic sensitivity which confers the mutation slt2 at the temperature of 37 °C. Said osmotic sensitivity may be used for releasing the intracellular content either by change of temperature of the culture from 24° to 37° C, or by transfer of grown cells in an osmotically stabilized medium at said second temperature to a non-stabilized medium. In both cases, the cells undergo a lysis and release their intracellular content and, after centrifugation to eliminate the cellular rests, a preparation of proteins is obtained which is appropriate to initiate a process of purification of the protein of interest. This process results in a cost reduction since the use of equipment is avoided and the preparation of proteins which is obtained contains less impurities than that which is obtained through other processes.

Description

TITULOTITLE
Procedimiento de liberación de proteínas heterólogas de cepas de Saccharomyces cerevisiae.Heterologous protein release procedure of Saccharomyces cerevisiae strains.
OBJETO DE LA INVENCIÓNOBJECT OF THE INVENTION
La presente invención se encuadra dentro de la Biotecnología y en concreto en el campo de la expresión, producción y liberación de proteínas heterólogas en la levadura. La invención proporciona un método para llevar a cabo dicha liberación, basado en tratamientos sencillos de determinadas cepas de Saccharomyces cerevisiae, portadoras de una mutación que conduce a la liberación del contenido intracelular, obteniéndose de esta forma preparaciones de proteínas que se separan fácilmente de la mayor parte de los materiales celulares indeseables presentes en dichas preparaciones, tales como paredes celulares. Las preparaciones de proteínas así obtenidas pueden ser sometidas a los procesos de extracción y purificación correspondientes. La mutación de la que son portadoras las células de Saccharomyces cerevisiae utilizadas en el procedimiento objeto de esta invención afecta al gen denominado SLT2; como consecuencia de dicha mutación las células pierden su integridad en determinadas condiciones lo que conduce a la liberación de su contenido de proteínas solubles. El conocimiento existente acerca de la función del citado gen, en buena medida desarrollado en nuestro laboratorio, permite aprovechar las características de este tipo de células mutantes para optimizar dicha liberación de proteínas. El procedimiento objeto de esta invención representa una alternativa a otros procedimientos de liberación de proteínas heterólogas de levadura tales como la rotura mecánica, química o enzimática de la integridad celular.The present invention falls within Biotechnology and specifically in the field of expression, production and release of heterologous proteins in yeast. The invention provides a method for carrying out said release, based on simple treatments of certain strains of Saccharomyces cerevisiae, carriers of a mutation that leads to the release of intracellular content, thus obtaining protein preparations that are easily separated from the greater part of the undesirable cellular materials present in said preparations, such as cell walls. Protein preparations thus obtained can be subjected to the corresponding extraction and purification processes. The mutation of which Saccharomyces cerevisiae cells are used in the process object of this invention affects the gene called SLT2; as a consequence of said mutation, the cells lose their integrity under certain conditions which leads to the release of their soluble protein content. The existing knowledge about the function of the aforementioned gene, largely developed in our laboratory, allows us to take advantage of the characteristics of this type of mutant cells to optimize said protein release. The process object of this invention represents an alternative to other methods of releasing heterologous yeast proteins such as mechanical, chemical or enzymatic breakage of cellular integrity.
ANTECEDENTESBACKGROUND
La levadura Saccharomyces cerevisiae es un organismo bien conocido y utilizado ampliamente en Biotecnología para la expresión y producción de proteínas heterólogas. Destacan varias características de esta especie en relación con la utilidad de la misma:The yeast Saccharomyces cerevisiae is a well known organism and widely used in Biotechnology for the expression and production of heterologous proteins. Several characteristics of this species stand out in relation to its usefulness:
HOJA SUSTITUIDA - es un organismo eucariótico.SUBSTITUTED SHEET - It is a eukaryotic organism.
- se trata de un organismo del tipo GRAS ("Generally Recognized As Safe") según la Food and Drug Administration (FDA) de los Estados Unidos. es decir generalmente reconocido como seguro, por ausencia de posibles contaminantes víricos y pirógenos; esto lo convierte en un hospedador apto para la producción de proteínas con uso alimentario y terapéutico.- it is an agency of the GRAS type ("Generally Recognized As Safe") according to the Food and Drug Administration (FDA) of the United States. that is to say generally recognized as safe, due to the absence of possible viral contaminants and pyrogens; This makes it a suitable host for the production of proteins with food and therapeutic use.
-existe un amplio conocimiento de su comportamiento a gran escala en fermentador por su uso en fermentaciones tradicionales.-There is a broad knowledge of its behavior on a large scale in fermenter for its use in traditional fermentations.
Las levaduras se utilizan para producir una serie proteínas heterólogas. de alto valor añadido, como consecuencia de un proceso de expresión de los correspondientes genes, en procesos en los que la proteína se acumula a nivel intracelular. Entre éstas están el antígeno de superficie del virus de la hepatitis B (HBV) que ha dado origen al desarrollo de una vacuna recombinante ya en el mercado, la proinsulina humana, la superóxido dismutasa humana, proteínas VLP como presentadoras de antigenos del virus HIV1 y el antígeno que ha permitido desarrollar una vacuna contra la malaria. Las posibilidades en este sentido se recogen ampliamente en Romanos, M.A., Scorer, C.A. and Clare, J.J. 1992, Foreign gene expression in yeast: a review. Yeast 8:423- 488.Yeasts are used to produce a series of heterologous proteins. of high added value, as a consequence of a process of expression of the corresponding genes, in processes in which the protein accumulates at the intracellular level. Among these are the surface antigen of the hepatitis B virus (HBV) that has given rise to the development of a recombinant vaccine already on the market, human proinsulin, human superoxide dismutase, VLP proteins as presenters of HIV1 virus antigens and the antigen that has allowed to develop a vaccine against malaria. The possibilities in this regard are widely collected in Romanos, M.A., Scorer, C.A. and Clare, J.J. 1992, Foreign gene expression in yeast: a review. Yeast 8: 423-488.
Para la recuperación de estas proteínas heterólogas producidas de forma intracelular normalmente se recurre a la rotura de las células. Los métodos descritos tradicionales para lograr dicha rotura celular son drásticos debido a la dureza de la pared celular de Saccharomyces cerevisiae y pueden consistir en: - rotura mecánica con homogeneizadores a presión (Schütte, H. andFor the recovery of these intracellularly produced heterologous proteins, cell breakage is usually used. The traditional methods described for achieving said cell rupture are drastic due to the hardness of the Saccharomyces cerevisiae cell wall and may consist of: - mechanical rupture with pressure homogenizers (Schütte, H. and
Kula, M.R. 1990. Pilot and process-scale techniques for cell disruption. Biotechnol. Appl. Biochem. 12:599-620).Kula, M.R. 1990. Pilot and process-scale techniques for cell disruption. Biotechnol Appl. Biochem 12: 599-620).
- rotura química empeando detergentes químicos (Breddam, K. and Beenfeldt, T. 1991. Acceleration of yeast autolysis by chemical methods for production of intracellular enzy es. Appl. Microbiol. Biotechnol. 35:323-329).- chemical breakage using chemical detergents (Breddam, K. and Beenfeldt, T. 1991. Acceleration of yeast autolysis by chemical methods for production of intracellular enzymes. Appl. Microbiol. Biotechnol. 35: 323-329).
- rotura enzimática empleando unas mezclas complejas de enzimas líticos (Asenjo, J.A., Ventom,A.M. Huang, R.B. and Andrews. B.A. 1993. Selective reléase of recombinant proteins particles (VLPs) from yeast using a puré lytic glucanase enzyme. Bio/Technology 11:214-217).- Enzymatic breakdown using complex mixtures of lithic enzymes (Asenjo, JA, Ventom, AM Huang, RB and Andrews. BA 1993. Selective relay of recombinant proteins particles (VLPs) from yeast using a puree lytic glucanase enzyme. Bio / Technology 11: 214-217).
Estos métodos presentan como inconvenientes la posible degradación de los polipéptidos debido a las altas presiones que pueden sufrir en los homogeneizadores. la posible contaminación que pueden suponer los compuestos químicos utilizados para laThese methods have as disadvantages the possible degradation of the polypeptides due to the high pressures they may suffer in the homogenizers. the possible contamination that the chemical compounds used for the
HOJA SUSTITUIDA extracción de la proteína que no siempre son fáciles de eliminar y, en el caso del uso de enzimas líticos. la contaminación con proteasas (Asenjo, J.A., Ventom.A.M.. Huang, R.B. and Andrews. B.A. 1993. Selective reléase of recombinant proteins particles (VLPs) fro yeast using a puré lytic glucanase enzyme. Bio/ echnology 11:214-217) que suelen estar presentes en los aludidos complejos de enzimas líticos. La alternativa de llevar a cabo una purificación para eliminar las proteasas aumenta el valor del complejo lítico que ya de por sí resulta caro.SUBSTITUTED SHEET Protein extraction is not always easy to eliminate and, in the case of the use of lithic enzymes. Protease contamination (Asenjo, JA, Ventom.AM. Huang, RB and Andrews. BA 1993. Selective relay of recombinant proteins particles (VLPs) fro yeast using a puree lytic glucanase enzyme. Bio / echnology 11: 214-217) that They are usually present in the aforementioned complexes of lytic enzymes. The alternative of carrying out a purification to eliminate proteases increases the value of the lithic complex that is already expensive in itself.
El problema técnico cuya resolución nos planteamos es lograr la liberación de proteínas heterólogas producidas intracelularmente en levadura, sin necesidad de tener que realizar un proceso de rotura mecánica, química o enzimática de las células. Para ello nos basamos en el uso de determinadas cepas deThe technical problem whose resolution we pose is to achieve the release of heterologous proteins produced intracellularly in yeast, without having to perform a process of mechanical, chemical or enzymatic breakage of the cells. For this we rely on the use of certain strains of
Saccharomyces cerevisiae portadoras de la mutación sltl, es decir que afecta al genSaccharomyces cerevisiae carrying the sltl mutation, that is to say it affects the gene
SLT2 descubierto y clonado en nuestro laboratorio (Torres, L., Martín, H., García- Saez, M.I., Arroyo, J., Molina, M., Sánchez, M. and Nombela, C. 1991. A protein kinase gene complements the lytic phenotype of Saccharomyces cerevisiae lyt2 mutants. Mol. Microbiol. 5:2845-2854; Fuente, J.M., Vázquez, A., González, M.,SLT2 discovered and cloned in our laboratory (Torres, L., Martín, H., García-Saez, MI, Arroyo, J., Molina, M., Sánchez, M. and Nombela, C. 1991. A protein kinase gene complements the lytic phenotype of Saccharomyces cerevisiae lyt2 mutants. Mol. Microbiol. 5: 2845-2854; Fuente, JM, Vázquez, A., González, M.,
Sánchez, M., Molina, M. and Nombela, C. 1993 Expression of mutations and protein reléase by yeast conditional autolytic mutants in batch and continuous cultures. Appl. Microbiol. Biotechnol. 38:763-769).Sánchez, M., Molina, M. and Nombela, C. 1993 Expression of mutations and protein relée by yeast conditional autolytic mutants in batch and continuous cultures. Appl. Microbiol Biotechnol 38: 763-769).
El gen SLT2 codifica una proteina con actividad fosforilante de proteinas, que se encuadra en el grupo de las llamadas "Proteína quinasas tipo MAP"(Mitogen Activated Protein) (Martín, H., Arroyo, J., Sánchez, M.. Molina, .M. and Nombela. C. 1993. Activity of the yeast MAP kinase homologue Slt2 is critically required for cell integrity at 37°C. Mol. Gen. GeneL 241: 177-184) y que cuya acción biológica parece enmarcarse en una ruta de transmisión de señales activadas por la proteína quinasa Cl, desconociéndose actualmente la señal que desencadena la activación de la ruta así como el sustrato final de la misma.The SLT2 gene encodes a protein with phosphorylating activity of proteins, which is part of the group called "Protein kinase type MAP" (Mitogen Activated Protein) (Martín, H., Arroyo, J., Sánchez, M .. Molina, .M. And Nombela. C. 1993. Activity of the yeast MAP kinase homologue Slt2 is critically required for cell integrity at 37 ° C. Mol. Gen. GeneL 241: 177-184) and whose biological action seems to be framed in a route of signal transmission activated by the protein kinase Cl, the signal that triggers the activation of the route as well as the final substrate thereof is currently unknown.
Otro factor a tener en cuenta a la hora de abordar la expresión de proteínas heterólogas en levaduras es la posibilidad de degradación proteolítica inespecífica de la correspondiente proteína, producida por acción de las proteasas de la levadura especialmente de las de origen vacuolar como son las codificadas por los genes PEP4 y -PΛ-S7 (Wingfield, J.M. and Dickinson, J.R. 1993. Increased activity of a model heterologous protein in Saccharomyces cerevisiae strains with reduced vacuolar proteinases. Appl. Microbiol. Biotechnol. 39:211-215; Jones, E.W. 1991. Tackling the protease problem in Saccharomyces cerevisiae . Meth. in Enzymol. 194:428-453;Another factor to consider when addressing the expression of heterologous proteins in yeasts is the possibility of nonspecific proteolytic degradation of the corresponding protein, produced by the action of yeast proteases, especially those of vacuolar origin such as those encoded by PEP4 and -PΛ-S7 genes (Wingfield, JM and Dickinson, JR 1993. Increased activity of a model heterologous protein in Saccharomyces cerevisiae strains with reduced vacuolar proteinases. Appl. Microbiol. Biotechnol. 39: 211-215; Jones, EW 1991 Tackling the protease problem in Saccharomyces cerevisiae Meth in Enzymol 194: 428-453;
STITUIDA Pohlig, G.. Zimmermann, W. and Heim, J. 1991. Influence of yeast proteases on hirudin expression in Saccharomyces cerevisiae . Biomed. Biochim. Acta 50:711-716). Por ello, también hemos desarrollado cepas más adecuadas para nuestra invención, es decir portadoras del carácter lítico (slt2), pero que son también deficientes en proteasas vacuolares.REPLACED Pohlig, G .. Zimmermann, W. and Heim, J. 1991. Influence of yeast proteases on hirudin expression in Saccharomyces cerevisiae. Biomed Biochim Minutes 50: 711-716). Therefore, we have also developed strains more suitable for our invention, that is, carriers of the lithic character (slt2), but which are also deficient in vacuolar proteases.
Los primeros estudios de liberación de proteínas heterólogas de acuerdo con el procedimiento de esta invención se realizaron induciendo la lisis celular mediante un choque térmico, consistente en elevar la temperatura del cultivo desde 24°C a 37°C, alcanzándose a las 6 a 8 horas la máxima liberación de proteínas, por ser ese el tiempo requerido para lograr una lisis del cultivo.The first studies of heterologous protein release according to the procedure of this invention were performed by inducing cell lysis by thermal shock, consisting of raising the temperature of the culture from 24 ° C to 37 ° C, reaching 6 to 8 hours maximum protein release, as that is the time required to achieve a culture lysis.
EXPLICACIÓN Y DESCRIPCIÓN DE LA INVENCIÓNEXPLANATION AND DESCRIPTION OF THE INVENTION
El proceso objeto de patente consiste en la utilización de diferentes cepas de Saccharomyces cerevisiae, deficientes en la función del gen SLT2, cuyo fenotipo se caracteriza por:The patent process consists in the use of different strains of Saccharomyces cerevisiae, deficient in the function of the SLT2 gene, whose phenotype is characterized by:
-crecimiento termosensible, de forma que las células se desarrollan bien a 24°C pero dejan de crecer y se lisan cuando se eleva la temperatura a 37°C, produciéndose la lisis celular con liberación del contenido intracelular al medio ex temo. -las células mutantes sltl resultan protegidas frente a las deficiencias indicadas anteriormente, es decir termosensibilidad y lisis a 37"C, por estabilización osmótica del medio con sorbitol 0.5M o NaCl 1.5%, lo que es indicativo de que la proteína codificada por el referido gen es necesaria para la formación de una pared celular osmóticamente estable a la temperatura de 37°C.-Thermosensitive growth, so that the cells develop well at 24 ° C but stop growing and lysate when the temperature rises to 37 ° C, producing cell lysis with release of intracellular content to the external medium. -sltl mutant cells are protected against the deficiencies indicated above, ie thermosensitivity and lysis at 37 "C, by osmotic stabilization of the medium with 0.5M sorbitol or 1.5% NaCl, which is indicative of the protein encoded by the referred gene is necessary for the formation of an osmotically stable cell wall at the temperature of 37 ° C.
El objetivo de la invención es el aprovechamiento de estas características fenotípicas para lograr la liberación de proteínas heterólogas producidas intracelularmente. Dicha liberación se basa en la lisis celular que se produce en determinadas condiciones y que conduce a la liberación de contenido intracelular que dichas cepas mutantes presentan cuando la temperatura de crecimiento se eleva de 24*C a 37*C o cuando, después de crecer a 37*C pero en medio estabilizado osmóticamente, son sometidas a un choque osmótico por simple resuspensión de las células en un medio carente de dicho estabilizador osmótico. Se obtiene de esta formaThe objective of the invention is to take advantage of these phenotypic characteristics to achieve the release of intracellularly produced heterologous proteins. Said release is based on the cell lysis that occurs under certain conditions and that leads to the release of intracellular content that said mutant strains present when the growth temperature rises from 24 * C to 37 * C or when, after growing at 37 * C but in an osmotically stabilized medium, they are subjected to an osmotic shock by simple resuspension of the cells in a medium lacking said osmotic stabilizer. It is obtained in this way
HOJA SUSTITUIDA una preparación de proteínas, que se separa de los restos del material celular por centrifugación simple, y en la que está presentes las proteínas heterólogas intracelulares en cantidades superiores al 50% del total de proteína intracelular producida.SUBSTITUTED SHEET a protein preparation, which is separated from the remains of the cellular material by simple centrifugation, and in which the intracellular heterologous proteins are present in amounts greater than 50% of the total intracellular protein produced.
Las cepas de Saccharomyces cerevisiae desarrolladas para llevar a cabo la invención son:The strains of Saccharomyces cerevisiae developed to carry out the invention are:
- LD1: es una cepa diploide portadora de la mutación slt2 con las características fenotípicas enunciadas con anterioridad. Su genotipo es: MATa MATa, slt2D-35/slt2D-35, Ieu2-3.U2/Ieu2-3.U2, his4Δ34/his4A34.- LD1: is a diploid strain carrying the slt2 mutation with the phenotypic characteristics listed above. Its genotype is: MATa MATa, slt2D-35 / slt2D-35, Ieu2-3.U2 / Ieu2-3.U2, his4Δ34 / his4A34.
- LHDP1: MAT a, slt2D-35, ade2-101, leu2-3.112, pep4::HIS3, pbrlA1.6R. Muestra las mismas características fenotípicas referidas a lisis, siendo además deficiente en proteasas vacuolares Pep4 y Prbl responsables de la proteolisis inespecífica.- LHDP1: MAT a, slt2D-35, ade2-101, leu2-3.112, pep4 :: HIS3, pbrlA1.6R. It shows the same phenotypic characteristics related to lysis, being also deficient in vacuolar proteases Pep4 and Prbl responsible for the nonspecific proteolysis.
Ambas cepas se encuentran depositadas en la Colección Española de Cultivos Tipo (CECT) sita en la Universidad de Valencia. Los números de acceso son: 10815 para la cepa LD1 y 10816 para la cepa LHDP1.Both strains are deposited in the Spanish Type Culture Collection (CECT) located at the University of Valencia. The access numbers are: 10815 for strain LD1 and 10816 for strain LHDP1.
El procedimiento de liberación de proteínas se puede llevar a cabo según se indica en las Figuras I y II por una de las siguientes alternativas:The protein release procedure can be carried out as indicated in Figures I and II by one of the following alternatives:
A) Liberación de proteínas por choque osmótico. Las fases del proceso se describen en la Figura I.A) Protein release by osmotic shock. The phases of the process are described in Figure I.
-crecimiento de la cepa muíante en el gen SLT2 a la temperatura restrictiva de 37*C en presencia de un estabilizador osmótico hasta mitad de la fase exponencial.-growth of the mutant strain in the SLT2 gene at the restrictive temperature of 37 * C in the presence of an osmotic stabilizer up to half of the exponential phase.
-separación de las células del medio de cultivo por centrifugación guardando las células.-separation of the cells from the culture medium by centrifugation keeping the cells.
-choque osmótico de las células mediante resuspensión de las mismas en agua, lo que conduce a la lisis de las mismas con liberación de las proteínas intracelulares, entre ellas la proteína heteróloga de interés.- Osmotic shock of the cells by resuspension of them in water, which leads to the lysis of them with the release of intracellular proteins, including the heterologous protein of interest.
-eliminación de los restos celulares por centrifugación obteniéndose una preparación cruda de proteínas intracelulares entre las que se encuentra la proteína de interés, y preparación que es apta para iniciar procesos de purificación.-elimination of cell debris by centrifugation obtaining a crude preparation of intracellular proteins among which is the protein of interest, and preparation that is suitable for initiating purification processes.
HOJA SUSTITUIDA B) Liberación de proteínas por choque térmico. Las fases del proceso son:SUBSTITUTED SHEET B) Protein release by thermal shock. The phases of the process are:
-crecimiento de la cepa mutante en el gen SLT2 a la temperatura permisiva de 24°C hasta la mitad de la fase exponencial.-growth of the mutant strain in the SLT2 gene at the permissible temperature of 24 ° C until half of the exponential phase.
-choque térmico del cultivo mediante elevación de la temperatura de crecimiento a 37°C, lo que produce la lisis de las células al cabo 6-8 horas de incubación a esa temperatura, con liberación del contenido intracelular al medio de cultivo.- thermal shock of the culture by raising the growth temperature to 37 ° C, which causes lysis of the cells after 6-8 hours of incubation at that temperature, with release of the intracellular content to the culture medium.
-separación de los restos celulares del medio de cultivo (que contiene las proteínas liberadas como resultado de la lisis celular) por centrifugación, obteniéndose al igual que en el caso anterior una preparación cruda de proteínas, portadora de la proteína de interés, apta para abordar procesos de purificación.-separation of cell debris from the culture medium (containing the proteins released as a result of cell lysis) by centrifugation, obtaining as in the previous case a crude protein preparation, carrier of the protein of interest, suitable for addressing purification processes
En la Figura II se explican los parámetros que nos indican que existe lisis del cultivo con liberación del contenido intracelular al medio de cultivo.The parameters that indicate that there is lysis of the culture with release of intracellular content to the culture medium are explained in Figure II.
Las principales ventajas que presenta la invención son las siguientes:The main advantages of the invention are the following:
- permite lograr una liberación suave y rápida de las proteínas evitando el uso de altas presiones en los homogeneizadores (Schütte, H. and Kula, M.R. 1990. Pilot and process-scale techniques for cell disruption. Biotechnol. Appl. Biochem. 12:599-620), de productos químicos (Breddam, K. and Beenfeldt, T. 1991. Acceleration of yeast autolysis by chemical methods for production of intracellular enzymes. Appl. Microbiol. Biotechnol. 35:323-329) y de enzimas líticos (Asenjo. J.A., Ventom,A.M., Huang, R.B. and Andrews, B.A. 1993. Selective reléase of recombinant proteins particles (VLPs) from yeast using a puré lytic glucanase enzyme. Bio/Technology 11:214-217) para digerir la pared; lo que además se traduce en un abaratamiento del proceso.- allows to achieve a smooth and rapid release of proteins avoiding the use of high pressures in the homogenizers (Schütte, H. and Kula, MR 1990. Pilot and process-scale techniques for cell disruption. Biotechnol. Appl. Biochem. 12: 599 -620), of chemical products (Breddam, K. and Beenfeldt, T. 1991. Acceleration of yeast autolysis by chemical methods for production of intracellular enzymes. Appl. Microbiol. Biotechnol. 35: 323-329) and lithic enzymes (Asenjo JA, Ventom, AM, Huang, RB and Andrews, BA 1993. Selective relée of recombinant proteins particles (VLPs) from yeast using a puree lytic glucanase enzyme Bio / Technology 11: 214-217) to digest the wall; which also translates into a cheaper process.
- evita las contaminaciones de la preparación de proteínas que se pueden dar en el caso de extracción con productos químicos que añaden impurezas a las preparaciones de proteínas no siempre fáciles de eliminar (Breddam. K. and Beenfeldt, T. 1991. Acceleration of yeast autolysis by chemical methods for production of intracellular enzymes. Appl. Microbiol. Biotechnol. 35:323-329) o de las contaminaciones con proteasas en el caso de extracción con enzimas líticos que se traduce en degradación de los polipéptidos (Asenjo, J.A., Ventom.A.M., Huang, R.B. and Andrews, B.A. 1993. Selective reléase of recombinant proteins particles (VLPs) from yeast using a puré lytic glucanase enzyme. Bio Technology 11:214-217).- prevents contamination of the protein preparation that can occur in the case of extraction with chemicals that add impurities to protein preparations not always easy to remove (Breddam. K. and Beenfeldt, T. 1991. Acceleration of yeast autolysis by chemical methods for production of intracellular enzymes. Appl. Microbiol. Biotechnol. 35: 323-329) or of protease contamination in the case of lithic enzyme extraction that results in degradation of the polypeptides (Asenjo, JA, Ventom. AM, Huang, RB and Andrews, BA 1993. Selective relay of recombinant proteins particles (VLPs) from yeast using a puree lytic glucanase enzyme. Bio Technology 11: 214-217).
- la posibilidad de concentrar el volumen de cultivo inicial, al producir el choque osmótico junto al hecho de que las proteínas heterólogas pueden ser- the possibility of concentrating the initial culture volume, producing the osmotic shock together with the fact that heterologous proteins can be
HOJA SUSTITUIDA expresadas bajo el control de promotores fuertes lo que significa que su proporción relativa puede ser elevada lo que facilita la posterior purificación de la misma.SUBSTITUTED SHEET expressed under the control of strong promoters which means that their relative proportion can be high which facilitates the subsequent purification thereof.
- la principal ventaja respecto al sistema similar basado en el empleo de la mutación srbl es la mayor sensibilidad al choque osmótico de la mutación slt2 en la que 60-70% de las células se lisan frente a un 20% de las células mutadas en -yrW(Bróker, M. 1994. Isolation of recombinant proteins from Saccharomyces cerevisiae by use of osmoücally fragüe mutant strains. Biotechniques 16:604-610). - the main advantage over the similar system based on the use of the srbl mutation is the greater sensitivity to osmotic shock of the slt2 mutation in which 60-70% of the cells are lysed against 20% of the cells mutated in - yrW (Broker, M. 1994. Isolation of recombinant proteins from Saccharomyces cerevisiae by use of osmoücally fragüe mutant strains. Biotechniques 16: 604-610).
BREVE DESCRIPCIÓN DE LOS DIBUJOSBRIEF DESCRIPTION OF THE DRAWINGS
Para facilitar la comprensión de las características de la invención se adjuntan dos Figuras explicativas. La Figura I muestra las fases del proceso de liberación de proteínas heterólogas intracelulares en cepas de Saccharomyces cerevisiae mutadas en el gen SLT2 por medio de un choque osmótico.To facilitate the understanding of the features of the invention, two explanatory figures are attached. Figure I shows the phases of the process of releasing intracellular heterologous proteins in strains of Saccharomyces cerevisiae mutated in the SLT2 gene by means of an osmotic shock.
En los cuatro paneles de la Figura II se describe la liberación de proteínas homologas (fosfatasa alcalina) y heterólogas (cloranfenicol acetil transferasa) de las cepas de Saccharomyces cerevisiae LDl (A,C) y LHDPl (B,D) transformadas con el plásmido pCHIOOL en condiciones de expresión de la mutación slt2. Cultivos realizados en un fermentador de 101 incubados a 24°C todo el cultivo (A y B) o cambiados a 37°C (C y D) (T, cambio de temperatura). Los parámetros medidos fueron:: +, viabilidad medida como porcentaje de células IP(-), , Densidad Óptica a 600 nm (DO); X , Proteína total en el medio de cultivo (Prot.); *, actividad cloranfenicol acetil transferasa (CAT) en extractos celulares (EC) y • , medio de cultivo (M) como unidades por mililitro; * , actividad fosfatasa alcalina (PA) en extractos celulares (EC) y A, medio de cultivo (M) como unidades por mililitro.The four panels in Figure II describe the release of homologous (alkaline phosphatase) and heterologous (chloramphenicol acetyl transferase) proteins from the strains of Saccharomyces cerevisiae LDl (A, C) and LHDPl (B, D) transformed with the plasmid pCHIOOL under conditions of expression of the slt2 mutation. Crops made in a 101-fermentor incubated at 24 ° C throughout the crop (A and B) or changed at 37 ° C (C and D) (T, temperature change). The parameters measured were: +, viability measured as a percentage of IP cells (-),, Optical Density at 600 nm (OD); X, Total protein in the culture medium (Prot.); *, chloramphenicol acetyl transferase (CAT) activity in cell extracts (EC) and •, culture medium (M) as units per milliliter; *, alkaline phosphatase (PA) activity in cell extracts (EC) and A, culture medium (M) as units per milliliter.
HOJA SUSTITUIDA EXPOSICI N DETALLADA DE UN MODO DE REALIZACIÓN DE LA INVENCIÓNSUBSTITUTED SHEET DETAILED EXHIBITION OF AN EMBODIMENT OF THE INVENTION
A continuación expondremos por medio de un ejemplo, no limitativo de su alcance, un modo de realización de la invención en las dos modalidades expuestas anterriormente.We will now explain by way of an example, not limiting its scope, an embodiment of the invention in the two modalities set forth above.
Las cepas de Saccharomyces cerevisiae empleadas son las descritas con anterioridad en el apartado de "Explicación y Descripción de la Invención"; además con carácter optativo se puede utilizar una cepa silvestre para el carácter lítico que sirva de control negativo en el experimento, por ejemplo nosotros hemos utilizado:The strains of Saccharomyces cerevisiae used are those described previously in the section "Explanation and Description of the Invention"; In addition, an optional wild strain can be used for the lithic character that serves as a negative control in the experiment, for example we have used:
- BJ5461: es una cepa silvestre para el gen SLT2 accesible al público en la colección denominada Yeast Genetic Stock Center (Mortimer, R.K. and Contopoulou, R. Yeast Genetic Stock Center Catalogue. Seventh edition 1991). No obstante se puede emplear como cepa control para los experimentos cualquier cepa no lírica.- BJ5461: It is a wild strain for the SLT2 gene accessible to the public in the collection called Yeast Genetic Stock Center (Mortimer, R.K. and Contopoulou, R. Yeast Genetic Stock Center Catalog. Seventh edition 1991). However, any non-lyric strain can be used as a control strain for the experiments.
Las tres cepas (LDl, LHDPl y BJ5461) se transforman con el plásmido pCHIOOL (Hadfield, C, Cashmore, A.M. and Meacock, P.A. 1986. An efficient chloramphenicol- resistance marker for Saccharomyces cerevisiae and Escherichia coli. Gene 45:149-158), modificado en nuestro laboratorio introduciendo un marcador LEU2 (leucina) para poder seleccionar transformantes. El plásmido codifica para la proteína CAT (Cloranfenicol Acetil Transferasa) de origen bacteriano y responsable de la resistencia a cloranfenicol y que es una proteína heteróloga para la levadura y además es producida de forma intracelular y por tanto sólo será detectable en el medio de cultivo como consecuencia de lisis celular.The three strains (LDl, LHDPl and BJ5461) are transformed with the plasmid pCHIOOL (Hadfield, C, Cashmore, AM and Meacock, PA 1986. An efficient chloramphenicol resistance marker for Saccharomyces cerevisiae and Escherichia coli. Gene 45: 149-158) , modified in our laboratory by introducing a LEU2 marker (leucine) to select transformants. The plasmid encodes the CAT (Chloramphenicol Acetyl Transferase) protein of bacterial origin and responsible for chloramphenicol resistance and is a heterologous protein for yeast and is also produced intracellularly and therefore will only be detectable in the culture medium as consequence of cell lysis.
Estudios previos han demostrado una buena estabilidad del plásmido lo que permite trabajar con medio no selectivo tipo YEPD (extracto de levadura 1%, peptona 2%, glucosa 2%) que permite un crecimiento más rápido y una mejor expresión del fenotipo lírico.Previous studies have demonstrated a good stability of the plasmid which allows working with a non-selective YEPD type (1% yeast extract, 2% peptone, 2% glucose) that allows faster growth and better expression of the lyric phenotype.
A) Liberación de proteínas por choque osmótico. Las fases del proceso están sumarizadas en la Figura I, incluida en el apartado de "Explicación y descripción de la invención".A) Protein release by osmotic shock. The process phases are summarized in Figure I, included in the "Explanation and description of the invention" section.
Las cepas transformadas se cultivan en medio YEPD líquido suplementado con un estabilizador osmótico (sorbitol 0.5M, NaCl 1.5%) a la temperatura de 37°C en un agitador termostatizado hasta la mitad de la fase exponencial. Antes de recoger lasThe transformed strains are grown in liquid YEPD medium supplemented with an osmotic stabilizer (0.5M sorbitol, 1.5% NaCl) at a temperature of 37 ° C on a thermostated stirrer until half of the exponential phase. Before picking up the
HOJA células para separarlas del medio de cultivo se toman muestras de sobrenadante y de células para obtener valores de referencia acerca de la liberación de CAT al medio externo (son negativos debido a que la ausencia de lisis hace que no haya liberación de contenido intracelular al medio externo). Los valores que se van a medir son la actividad de CAT en el extracto celular y en el sobrenadante antes y después del choque osmótico para establecer la cantidad de proteína liberada desde las células al sobrenadante, siguiendo un método colorimétrico descrito por Hadfield, C, Cashmore, A.M. and Meacock, P.A. 1986. An efficient chloramphenicol- resistance marker for Saccharomyces cerevisiae and Escherichia coli. Gene 45:149-158). Como se indica en la Figura I las células son separadas por una centrifugación a 5000rpm durante 5', siendo a continuación resuspendidas en agua, momento en el cual se vuelve a tomar otra muestra separando por centrifugación a 5000rpm 10 min los restos celulares y analizando la cantidad de CAT presente en las células y en sobrenadante mostrándose los datos en la tabla I, esta preparación obtenida tras la segunda centrifugación deja una preparación de proteínas lista para acometer un proceso de purificación de la proteína de interés.SHEET Cells to separate them from the culture medium are taken samples of supernatant and cells to obtain reference values about the release of CAT to the external medium (they are negative because the absence of lysis causes that there is no release of intracellular content to the external medium ). The values to be measured are the activity of CAT in the cell extract and in the supernatant before and after the osmotic shock to establish the amount of protein released from the cells to the supernatant, following a colorimetric method described by Hadfield, C, Cashmore , AM and Meacock, PA 1986. An efficient chloramphenicol- resistance marker for Saccharomyces cerevisiae and Escherichia coli. Gene 45: 149-158). As indicated in Figure I, the cells are separated by centrifugation at 5000rpm for 5 ', then they are resuspended in water, at which time another sample is taken again by centrifuging the cell debris at 5000rpm for 10 min and analyzing the amount of CAT present in the cells and in the supernatant showing the data in table I, this preparation obtained after the second centrifugation leaves a protein preparation ready to undertake a process of purification of the protein of interest.
Como era de esperar la cepa silvestre, en este caso BJ5461, no es osmóticamente sensible y no se observa aparición de actividad CAT en el sobrenadante, a diferencia de las otras dos cepas que sí son sensibles al choque osmótico y que presentan un 60-70% de su actividad en el sobrenadante. Destaca la mayor productividad de la cepa LHDPl en concordancia con lo publicado en otros trabajos (Romanos, M.A., Scorer, C.A. and Clare, J.J. 1992, Foreign gene expression in yeast: a review. Yeast 8:423-488; Wingfield, J.M. and Dickinson, J.R. 1993. Increased activity of a model heterologous protein in Saccharomyces cerevisiae strains with reduced vacuolar proteinases. Appl. Microbiol. Biotechnol. 39:21 1-215). Estos datos están apoyados en medidas paralelas de proteína total presente en los extractos celulares y en los sobrenadantes siguiendo el método colorimétrico descrito por Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principie of protein-dye binding. Analyt. Biochem. 72:248-254, mostrando perfiles similares a los de la actividad CAT.As expected, the wild strain, in this case BJ5461, is not osmotically sensitive and there is no occurrence of CAT activity in the supernatant, unlike the other two strains that are sensitive to osmotic shock and have a 60-70 % of its activity in the supernatant. Highlights the higher productivity of the LHDPl strain in accordance with what has been published in other studies (Romanos, MA, Scorer, CA and Clare, JJ 1992, Foreign gene expression in yeast: a review. Yeast 8: 423-488; Wingfield, JM and Dickinson, JR 1993. Increased activity of a model heterologous protein in Saccharomyces cerevisiae strains with reduced vacuolar proteins. Appl. Microbiol. Biotechnol. 39:21 1-215). These data are supported by parallel measures of total protein present in cell extracts and supernatants following the colorimetric method described by Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principie of protein-dye binding. Analyt Biochem 72: 248-254, showing profiles similar to those of the CAT activity.
HOJA SUSTITUIDA TABLA ISUBSTITUTED SHEET TABLE I
ACTIVIDAD CAT (UE/ml)CAT ACTIVITY (EU / ml)
YEPD+ soibitol 37*C H2OYEPD + soibitol 37 * CH 2 O
Cepas Extracto celular Sobrenadante Extracto celular Sobrenadante %CAT §Strains Cell extract Supernatant Cell extract Supernatant% CAT §
BJ5461 100 n.d. 98 n-d. 0BJ5461 100 n.d. 98 n-d. 0
LDl 75 n.d 23 50 70LDl 75 n.d 23 50 70
LHDPl 220 n-d. 80 130 60LHDPl 220 n-d. 80 130 60
n.d.: no detectadon.d .: not detected
§:%CAT liberado al sobrenadante§:% CAT released to the supernatant
Tabla I: Liberación de la proteína heteróloga CAT por choque osmótico de cepas slt2 . Se tomaron muestras de igual densidad celular y la actividad CAT fue deteπninada en: extracto celular (antes y después del choque osmótico), sobrenadante de medio de cultivo o de agua en la que se resuspendieron las células después del choque osmótico.Table I: Release of the heterologous CAT protein by osmotic shock of strains slt2. Samples of equal cell density were taken and the CAT activity was detected in: cell extract (before and after the osmotic shock), culture medium or water supernatant in which the cells were resuspended after the osmotic shock.
HOJA SUSTITUIDA B) Liberación de proteínas por choque térmico. Los datos obtenidos en experimentos tipo se muestran en la Figura II.SUBSTITUTED SHEET B) Protein release by thermal shock. The data obtained in type experiments are shown in Figure II.
Los experimentos en esta modalidad se han realizado utilizando un fermentador con cuba de 101 de volumen de trabajo modelo BIOSTAT E (Braun); lo que confiere a los resultados un valor adicional ya que un fermentador de estas características representa una escala superior a la del matraz y se acerca a la escala de planta piloto. Las condiciones de cultivo fueron: -medio de cultivo YEPDExperiments in this modality have been carried out using a 101-volume cutaway fermenter model BIOSTAT E (Braun); which gives the results an additional value since a fermenter of these characteristics represents a scale greater than that of the flask and approaches the pilot plant scale. The culture conditions were: -YEPD culture medium
-temperatura: inicial de 24°C elevándose la misma a 37°C a la mitad de la fase exponencial, para provocar la lisis y la consiguiente liberación de proteínas al medio de cultivo.-Temperature: initial of 24 ° C rising the same to 37 ° C in the middle of the exponential phase, to cause lysis and the consequent release of proteins to the culture medium.
-datos técnicos:-technical data:
-el inoculo se obtenía cultivando las células a 24°C en medio mínimo sin leucina para asegurar un 100% de células portadoras del plásmido. Su volumen era de 500ml y correspondía a un cultivo en fase estacionaria.-The inoculum was obtained by culturing the cells at 24 ° C in minimal medium without leucine to ensure 100% plasmid carrying cells. Its volume was 500ml and corresponded to a stationary phase culture.
-el cultivo era de tipo discontinuo (batch). -la velocidad de agitación era de 300rpm, el pH oscilaba entre 4 y 6, el flujo de entrada de aire 5 1/min.-The crop was batch type. -the stirring speed was 300rpm, the pH ranged between 4 and 6, the air inlet flow 5 1 / min.
-toma de muestras: se realizaron tomas periódicas a 24° y 37°C con el fin de seguir la evolución de la densidad óptica y la viabilidad del cultivo. Además para evaluar la proteína total y la actividad enzimática CAT se tomaron una o dos muestras antes del choque térmico y tras este a intervalos más cortos al principio (3horas) incrementándose hasta las 24-30 horas posteriores al cambio de temperatura.-sampling: periodic shots were taken at 24 ° and 37 ° C in order to follow the evolution of the optical density and the viability of the culture. In addition, to evaluate the total protein and CAT enzymatic activity, one or two samples were taken before the thermal shock and after this at shorter intervals at the beginning (3 hours), increasing until 24-30 hours after the temperature change.
Con las condiciones mencionadas anteriormente el cultivo se mantenía a 24° C hasta una densidad óptica entre 1 y 1.5; en ese momento se cambiaba la temperatura del cultivo a 37°C para provocar la lisis de las células. Lo anterior y lo expuesto a continuación se refiere a datos mostrados en la Figura II en sus diferentes apartados. Para seguir la lisis se evaluaron los diferentes parámetros:Under the conditions mentioned above the culture was maintained at 24 ° C to an optical density between 1 and 1.5; at that time the temperature of the culture was changed to 37 ° C to cause cell lysis. The above and the following refers to data shown in Figure II in its different sections. To follow the lysis the different parameters were evaluated:
-lisis celular, que lógicamente significa la muerte celular, se medía siguiendo un método desarrollado en nuestro laboratorio consistente en medir el porcentaje de población celular que es teñida por el fluorocromo yoduro de propidio mediante la técnica de citometría de flujo (Fuente, J.M., Alvarez, A., Nombela. C. and Sánchez, M. 1992. Flow cytometric analysis of Saccharomyces cerevisiae autolytic mutants and protoplasts. Yeast 8:39-45) y que equivale a un perfil de la viabilidad del cultivo.Cellular analysis, which logically means cell death, was measured following a method developed in our laboratory consisting of measuring the percentage of cell population that is stained by fluorochrome propidium iodide using the flow cytometry technique (Source, JM, Alvarez , A., Nombela. C. and Sánchez, M. 1992. Flow cytometric analysis of Saccharomyces cerevisiae autolytic mutants and protoplasts. Yeast 8: 39-45) and equivalent to a profile of the viability of the crop.
HOJA SU -al igual que en el caso de liberación de proteínas por choque osmótico se medía la actividad enzimática de CAT y la proteína total. Se considera proteína liberada al incremento sobre el valor basal medido en el cultivo a 24°C inmediatamente antes de cambiar la temperatura a 37°C.SU SHEET -as in the case of osmotic shock protein release, the enzymatic activity of CAT and the total protein was measured. Protein released is considered to be the increase over the baseline value measured in the culture at 24 ° C immediately before changing the temperature to 37 ° C.
Los resultados expuestos en la Figura II (pág.15) corresponden a fermentaciones tipo de las cepas LDl y LHDPl. Las gráficas A (LDl) y C (LHDPl) a sendas fermentaciones realizadas a 24°C con el objeto de seguir el perfil de dichas cepas a su temperatura permisiva y poder establecer que en ningún momento se produce ni lisis (no se observa disminución del perfil de viabilidad) ni, por tanto, liberación de proteínas al medio de cultivo (la actividad CAT únicamente es detectable en el extracto celular, es decir en el interior de las células). Se puede decir que son dos fermentaciones que sirven de control para la comparación con las fermentaciones realizadas con choque térmico en las mismas cepas que nos permiten evaluar con más precisión el efecto de dicho choque térmico. En las gráficas B (DL1) y D (LHDPl), correspondientes a fermentaciones con choque térmico, se observan los siguientes fenómenos tras el cambio de temperatura, representado por un trazo vertical continuo en la gráfica:The results presented in Figure II (page 15) correspond to type fermentations of the LDl and LHDPl strains. The graphs A (LDl) and C (LHDPl) to fermentations carried out at 24 ° C in order to follow the profile of these strains at their permissive temperature and to establish that at no time does lysis occur (no decrease in the viability profile) or, therefore, protein release to the culture medium (CAT activity is only detectable in the cell extract, that is inside the cells). It can be said that there are two fermentations that serve as a control for the comparison with the fermentations performed with thermal shock in the same strains that allow us to more accurately assess the effect of said thermal shock. In the graphs B (DL1) and D (LHDPl), corresponding to fermentations with thermal shock, the following phenomena are observed after the temperature change, represented by a continuous vertical line in the graph:
-en ambas se observa una acusada pérdida de viabilidad hasta niveles en torno al 20 a 30% de células viables, como resultado de la expresión del fenotipo de la mutación en el gen SLT2 a la temperatura de 37°C.- in both of them a marked loss of viability is observed up to levels around 20 to 30% of viable cells, as a result of the expression of the phenotype of the mutation in the SLT2 gene at the temperature of 37 ° C.
-las dos cepas presentan liberación de proteínas al medio externo representada por el incremento observado en las proteínas totales, medidas por el método Bradford (Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principie of protein-dye binding. Analyt. Biochem. 72:248-254), y en la actividad enzimática CAT (Hadfield, C, Cashmore, A.M. and Meacock, P.A. 1986. An efficient chloramphenicol-resistance marker for Saccharomyces cerevisiae and Escherichia coli. Gene 45:149-158). Sin embargo la estabilidad de la enzima CAT demuestra ser superior en la cepa LHDPl que en la LDl, debido probablemente a no estar expuesta a la acción de las proteasas vacuolares Pep4 y Prbl en el caso de la cepa LHDPl.-the two strains present protein release to the external environment represented by the increase observed in total proteins, measured by the Bradford method (Bradford, MM 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principie of protein -dye binding. Analyt. Biochem. 72: 248-254), and in the enzymatic activity CAT (Hadfield, C, Cashmore, AM and Meacock, PA 1986. An efficient chloramphenicol-resistance marker for Saccharomyces cerevisiae and Escherichia coli. Gene 45 : 149-158). However, the stability of the CAT enzyme proves to be superior in the LHDP1 strain than in the LDl, probably due to not being exposed to the action of the vacuolar proteases Pep4 and Prbl in the case of the LHDP1 strain.
-al igual que en el caso del choque osmótico la separación de los restos celulares por centrifugación deja una preparación cruda de proteínas apta para emprender un proceso de purificación. - As in the case of osmotic shock, the separation of cell debris by centrifugation leaves a crude preparation of proteins suitable for undertaking a purification process.
PCT/ES1995/000088 1994-07-14 1995-07-14 Process for releasing heterolog proteins of saccharomyces cerevisiae strains WO1996002629A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU30787/95A AU3078795A (en) 1994-07-14 1995-07-14 Process for releasing heterolog proteins of saccharomyces cerevisiae strains

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP9401536 1994-07-14
ES9401536A ES2092439B1 (en) 1994-07-14 1994-07-14 RELEASE PROCEDURE OF HETEROLOGICAL PROTEINS FROM STRAINS OF SACCHAROMYCES CEREVISIAE.

Publications (3)

Publication Number Publication Date
WO1996002629A2 true WO1996002629A2 (en) 1996-02-01
WO1996002629A3 WO1996002629A3 (en) 1996-04-04
WO1996002629B1 WO1996002629B1 (en) 1996-05-23

Family

ID=8286899

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES1995/000088 WO1996002629A2 (en) 1994-07-14 1995-07-14 Process for releasing heterolog proteins of saccharomyces cerevisiae strains

Country Status (3)

Country Link
AU (1) AU3078795A (en)
ES (1) ES2092439B1 (en)
WO (1) WO1996002629A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060138A3 (en) * 1998-05-16 2000-01-20 Univ Manchester Regulated expression of pkc and/or srb1/psa1 in yeast
WO2005104649A3 (en) * 2004-04-30 2006-05-11 Consejo Superior Investigacion Autolytic yeasts (bgs4 delta), production method thereof and applications of same in protein expression methods

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 38, num. 6, páginas 763-769, JESŸS MANUEL DE LA FUENTE ET AL. 'Expression of mutations and protein release by yeast conditional autolytic mutants in batch and continuous cultures' citado en la solicitud *
BIOTECHNIQUES, vol. 16, num. 4, NATICK US, páginas 604-610, MICHAEL BRÖKER 'Isolation of recombinant proteins from Saccharomyces cerevisiae by use of osmotically fragile mutant strains' citado en la solicitud *
J. BIOTECHNOL. (1994), 38(1), 81-8 CODEN: JBITD4;ISSN: 0168-1656, ALVAREZ, PABLO ET AL 'A new system for the release of heterologous proteins from yeast based on mutant strains deficient in cell integrity' *
MOLECULAR AND GENERAL GENETICS, vol. 241, num. 1-2, BERLIN DE, páginas 177-184, HUMBERTO MARTÍN ET AL. 'Activity of the yeast MAP kinase homologue Slt2 is critically required for cell integrity at 37ŸC' citado en la solicitud *
MOLECULAR MICROBIOLOGY, vol. 5, num. 11, páginas 2845-2854, L. TORRES ET AL. 'A protein kinasr gene complements the lytic phenotype of Saccharomyces cerevisiae lyt2 mutants' citado en la solicitud *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060138A3 (en) * 1998-05-16 2000-01-20 Univ Manchester Regulated expression of pkc and/or srb1/psa1 in yeast
GB2353798A (en) * 1998-05-16 2001-03-07 Univ Manchester Regulated expression of PKC and/or SRB1/PSA1 in yeast
GB2353798B (en) * 1998-05-16 2003-11-12 Univ Manchester Regulated expression of SRB1/PSA1 in yeast
WO2005104649A3 (en) * 2004-04-30 2006-05-11 Consejo Superior Investigacion Autolytic yeasts (bgs4 delta), production method thereof and applications of same in protein expression methods

Also Published As

Publication number Publication date
WO1996002629A3 (en) 1996-04-04
AU3078795A (en) 1996-02-16
ES2092439B1 (en) 1997-07-01
ES2092439A1 (en) 1996-11-16

Similar Documents

Publication Publication Date Title
JP5354559B2 (en) Highly efficient secretory signal peptides and protein expression systems using them
Wesolowski‐Louvel et al. A nuclear gene required for the expression of the linear DNA‐asociated killer system in the yeast Kluyveromyces lactis
ES2464740T3 (en) Method to generate a genetically modified microbe
Higashiura et al. Magnaporthe oryzae chrysovirus 1 strain D confers growth inhibition to the host fungus and exhibits multiform viral structural proteins
Tan et al. Semliki Forest virus temperature-sensitive mutants: isolation and characterization
GB2034717A (en) Method for preparing recombinant
Beard et al. Detection of a protein, similar to the sex pilus subunit, in the outer membrane of Escherichia coli cells carrying a derepressed F-like R factor
Pang et al. Expression and characterization of recombinant human lactoferrin in edible alga Chlamydomonas reinhardtii
Wiemken Isolation of vacuoles from yeasts
WO1996002629A2 (en) Process for releasing heterolog proteins of saccharomyces cerevisiae strains
EP3713586B1 (en) Vibrio sp. organisms with modified lipopolysaccharide
Skotnicki et al. The first subantarctic plant virus report: Stilbocarpa mosaic bacilliform badnavirus (SMBV) from Macquarie Island
CN109266566A (en) A method of it adjusting torulopsis glabrata and permeates pressure stress
Diez et al. PCR with Paracoccidioides brasiliensis specific primers: potential use in ecological studies
Branduardi et al. Molecular tools and protocols for engineering the acid-tolerant yeast Zygosaccharomyces bailii as a potential cell factory
CN103013980A (en) Method for extracting bacillus subtilis genetically engineered bacterium plasmid
Luu et al. Development of conditional cell lysis mutants of Saccharomyces cerevisiae as production hosts by modulating OCH1 and CHS3 expression
Koga et al. Molecular characterization of a single mitochondria-associated double-stranded RNA in the green alga Bryopsis
WO2007117258A3 (en) Growth of wild-type hepatitis a virus in cell culture
Dai et al. Transformation of ψ− Saccharomyces cerevisiae to ψ+ with DNA co-purified with 3 μ m circles
JP6579862B2 (en) Shiitake with high lentinan content
Svoboda et al. Ultrastructure of Saccharomyces cerevisiae cells accumulating Golgi organelles
Seroussi et al. Detection of killer-independent dsRNA plasmids in Ustilago maydis by a simple and rapid method of extraction of dsRNA
Cavalcante et al. Evaluation of phenotypic and genotypic alterations induced by long periods of subculturing of Cryptococcus neoformans strains
Gomes et al. A vector carrying the GFP gene (Green fluorescent protein) as a yeast marker for fermentation processes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: CA

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载